Pill Can Cause Thrombosis

Among the wide selection of methods of contraception, birth control pills are perhaps the most popular in addition to condoms. Doctors often suggest it because it has a very high effectiveness in preventing pregnancy (almost 100% for the combination pill). Women of childbearing age also love it because it is practical, it is not necessary to have a worn or mounted. In addition, birth control pills have other benefits such as reducing the risk of tumor growth in breast and uterine cysts and have a positive impact on the skin by reducing acne and refine the skin.

However, behind these advantages, birth control pills seem to watch. Birth control pills can increase the risk of thrombosis (blood clots), especially the kind who wear drospirenon (synthetic progesterone which is very similar to natural progesterone). Vein thrombosis in harmful, even potentially deadly, because it can migrate to the lungs or brain, causing a pulmonary embolism and stroke. The highest risk found in women over the age of 35 years who smoke. Other risk factors are obesity and a family history of thrombosis and thromboembolism.

Concerns about an increased risk of thrombosis by drospirenon based pill is already quite long voiced, but apparently reached its peak in recent months. After more than 11,000 lawsuits filed over a wide range of health problems related to contraception, the agency the U.S. Food and Drug Administration (FDA) some time ago ordered that every product drospirenon-based birth control pills contain a warning about the risk of the package.

FDA cites several epidemiological studies showing that drospirenon based contraceptives increase the risk of thrombosis up to 300% compared to other types of birth control pills. Furthermore, health authorities stressed that the risk of thrombosis increased use of birth control pills in pregnancy, it does not matter whether or not the product contains drospirenon.

In the world, a major producer based drospirenon pill is Bayer. Bayer products based drospirenon with brands such as Yasmin, Yaz and Yasmin Elle've very popular in the world, with global sales in 2011 reached 1.07 billion euros (about Rp 10 trillion). With recent developments, Bayer U.S. now faces a barrage of lawsuits over health problems associated with the use of these products.